JANX
Janux Therapeutics, Inc.Company with tickers: JANX
CIK
1817713
CUSIP
47103J105
Shares Outstanding
60,984,354
Website
https://www.januxrx.com
Investor Relations
https://investors.januxrx.com/overview/default.aspx
13F Activity (30d)
9 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-12-05 | 2024-12-04 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| DEF 14A | 2025-04-25 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-09-19 | 2025-09-18 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2026-01-22 | 2026-01-21 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| DEF 14A | 2026-04-28 | 2026-06-11 | |
| 8-K | 2026-04-28 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-06-12 | 2026-06-11 |
Showing 51–71 of 71 filings